CMA
VRTX icon

Cedar Mountain Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Cedar Mountain Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.8K Hold
54
– – ﹤0.01% 277
2026
Q1 		$24.1K Buy
54
+16
+42% +$7.46K ﹤0.01% 257
2025
Q4 		$17.2K Hold
38
– – ﹤0.01% 199
2025
Q3 		$14.9K Buy
38
+3
+9% +$1.25K ﹤0.01% 215
2025
Q2 		$15.6K Hold
35
– – ﹤0.01% 184
2025
Q1 		$17K Sell
35
-2
-5% -$932 ﹤0.01% 167
2024
Q4 		$14.9K Sell
37
-7
-16% -$3.25K ﹤0.01% 178
2024
Q3 		$20.5K Hold
44
– – ﹤0.01% 149
2024
Q2 		$20.6K Hold
44
– – 0.01% 136
2024
Q1 		$18.4K Hold
44
– – ﹤0.01% 142
2023
Q4 		$17.9K Hold
44
– – ﹤0.01% 140
2023
Q3 		$15.3K Buy
+44
New +$15.4K ﹤0.01% 137

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
MLL
Moody Lynn & Lieberson Boston, Massachusetts $1.9B AUM 27.82% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Cedar Mountain Advisors's VRTX Position: Q2 2026 in Review

Cedar Mountain Advisors held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 54 shares worth $26.8K. The position accounts for ﹤0.01% of the portfolio, ranked #277.

Cedar Mountain Advisors first reported a position in VRTX in Q3 2023 and has held it in 12 quarters since. 296 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Cedar Mountain Advisors held 54 shares of Vertex Pharmaceuticals worth $26.8K as of Q2 2026.
  • Cedar Mountain Advisors left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up ﹤0.01% of Cedar Mountain Advisors's portfolio in Q2 2026, its #277 holding.
  • Cedar Mountain Advisors first reported a position in Vertex Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
  • 296 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Cedar Mountain Advisors's 13F filing for Q2 2026, filed 2 Jul 2026.